236 related articles for article (PubMed ID: 30337542)
1. DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage.
Xiao X; Liang J; Huang C; Li K; Xing F; Zhu W; Lin Z; Xu W; Wu G; Zhang J; Lin X; Tan Y; Cai J; Hu J; Chen X; Huang Y; Qin Z; Qiu P; Su X; Chen L; Lin Y; Zhang H; Yan G
Nat Commun; 2018 Oct; 9(1):4342. PubMed ID: 30337542
[TBL] [Abstract][Full Text] [Related]
2. A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1.
Li K; Liang J; Lin Y; Zhang H; Xiao X; Tan Y; Cai J; Zhu W; Xing F; Hu J; Yan G
Oncotarget; 2016 Jul; 7(30):48443-48455. PubMed ID: 27374176
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.
Li K; Hu C; Xing F; Gao M; Liang J; Xiao X; Cai J; Tan Y; Hu J; Zhu W; Yin W; Li Y; Chen W; Lu B; Mai J; Qiu P; Su X; Yan G; Zhang H; Lin Y
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263275
[TBL] [Abstract][Full Text] [Related]
4. Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1.
Li K; Zhang H; Qiu J; Lin Y; Liang J; Xiao X; Fu L; Wang F; Cai J; Tan Y; Zhu W; Yin W; Lu B; Xing F; Tang L; Yan M; Mai J; Li Y; Chen W; Qiu P; Su X; Gao G; Tai PW; Hu J; Yan G
Mol Ther; 2016 Feb; 24(1):156-65. PubMed ID: 26373347
[TBL] [Abstract][Full Text] [Related]
5. Selective Antagonism of Bcl-xL Potentiates M1 Oncolysis by Enhancing Mitochondrial Apoptosis.
Tan Y; Lin Y; Li K; Xiao X; Liang J; Cai J; Guo L; Li C; Zhu W; Xing F; Mai J; Gu J; Tan X; Yin W; Lu B; Qiu P; Su X; Gao M; Hu J; He S; Lu L; Gong S; Yan G; Zhang H
Hum Gene Ther; 2018 Aug; 29(8):950-961. PubMed ID: 28750564
[TBL] [Abstract][Full Text] [Related]
6. Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics.
Cai J; Lin Y; Zhang H; Liang J; Tan Y; Cavenee WK; Yan G
Proc Natl Acad Sci U S A; 2017 Jun; 114(26):6812-6817. PubMed ID: 28607091
[TBL] [Abstract][Full Text] [Related]
7. Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1.
Cai J; Lin K; Cai W; Lin Y; Liu X; Guo L; Zhang J; Xu W; Lin Z; Wong CW; Sander M; Hu J; Yan G; Zhu W; Liang J
Mol Oncol; 2020 Dec; 14(12):3153-3168. PubMed ID: 33037696
[TBL] [Abstract][Full Text] [Related]
8. Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade.
Marchini A; Scott EM; Rommelaere J
Viruses; 2016 Jan; 8(1):. PubMed ID: 26751469
[TBL] [Abstract][Full Text] [Related]
9. Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms.
Kim DS; Dastidar H; Zhang C; Zemp FJ; Lau K; Ernst M; Rakic A; Sikdar S; Rajwani J; Naumenko V; Balce DR; Ewanchuk BW; Tailor P; Yates RM; Jenne C; Gafuik C; Mahoney DJ
Nat Commun; 2017 Aug; 8(1):344. PubMed ID: 28839138
[TBL] [Abstract][Full Text] [Related]
10. Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma.
Zhang H; Li K; Lin Y; Xing F; Xiao X; Cai J; Zhu W; Liang J; Tan Y; Fu L; Wang F; Yin W; Lu B; Qiu P; Su X; Gong S; Bai X; Hu J; Yan G
Sci Transl Med; 2017 Aug; 9(404):. PubMed ID: 28835517
[TBL] [Abstract][Full Text] [Related]
11. Suppression of CCDC6 sensitizes tumor to oncolytic virus M1.
Liu Y; Li K; Zhu WB; Zhang H; Huang WT; Liu XC; Lin Y; Cai J; Yan GM; Qiu JG; Peng L; Liang JK; Hu C
Neoplasia; 2021 Jan; 23(1):158-168. PubMed ID: 33338804
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer.
Ganesh S; Gonzalez-Edick M; Gibbons D; Ge Y; VanRoey M; Robinson M; Jooss K
Cancer Gene Ther; 2009 May; 16(5):383-92. PubMed ID: 19011598
[TBL] [Abstract][Full Text] [Related]
13. First-in-class small molecule potentiators of cancer virotherapy.
Dornan MH; Krishnan R; Macklin AM; Selman M; El Sayes N; Son HH; Davis C; Chen A; Keillor K; Le PJ; Moi C; Ou P; Pardin C; Canez CR; Le Boeuf F; Bell JC; Smith JC; Diallo JS; Boddy CN
Sci Rep; 2016 May; 6():26786. PubMed ID: 27226390
[TBL] [Abstract][Full Text] [Related]
14. CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma.
Xiao J; Liang J; Fan J; Hou P; Li X; Zhang H; Li K; Bu L; Li P; He M; Zhong Y; Guo L; Jia P; Xiao Q; Wu J; Peng H; Li C; Xing F; Guo D
Cancer Res; 2022 Sep; 82(18):3359-3374. PubMed ID: 35792620
[TBL] [Abstract][Full Text] [Related]
15. In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.
McKenzie BA; Zemp FJ; Pisklakova A; Narendran A; McFadden G; Lun X; Kenchappa RS; Kurz EU; Forsyth PA
Neuro Oncol; 2015 Aug; 17(8):1086-94. PubMed ID: 25605818
[TBL] [Abstract][Full Text] [Related]
16. The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach.
Forte IM; Indovina P; Montagnaro S; Costa A; Iannuzzi CA; Capone F; Camerlingo R; Malfitano AM; Pentimalli F; Ferrara G; Quintiliani M; Portella G; Giordano A; Ciarcia R
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960727
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus.
Liang J; Guo L; Li K; Xiao X; Zhu W; Zheng X; Hu J; Zhang H; Cai J; Yu Y; Tan Y; Li C; Liu X; Hu C; Liu Y; Qiu P; Su X; He S; Lin Y; Yan G
Nat Commun; 2018 Apr; 9(1):1524. PubMed ID: 29670091
[TBL] [Abstract][Full Text] [Related]
18. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M
J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.
Gomez-Gutierrez JG; Nitz J; Sharma R; Wechman SL; Riedinger E; Martinez-Jaramillo E; Sam Zhou H; McMasters KM
Virology; 2016 Jan; 487():249-59. PubMed ID: 26561948
[TBL] [Abstract][Full Text] [Related]
20. Liposome Encapsulation of Oncolytic Virus M1 To Reduce Immunogenicity and Immune Clearance in Vivo.
Wang Y; Huang H; Zou H; Tian X; Hu J; Qiu P; Hu H; Yan G
Mol Pharm; 2019 Feb; 16(2):779-785. PubMed ID: 30604617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
